Prevenção Quaternária e limites em medicina*,**
DOI:
https://doi.org/10.5712/rbmfc9(31)867Palavras-chave:
Conflito de Interesses, Medicalização, Prevenção Quaternária, Medicina de Família e ComunidadeResumo
O conceito de Prevenção Quaternária, um questionamento sobre a base da ação médica, nasceu na articulação da relação médico-paciente. Refere-se a toda a atividade médica, sendo uma importante ferramenta para a medicina de família. É uma interrogação ética sobre os excessos da demasiada e demasiadamente pouca medicina e fornece algumas respostas.
Downloads
Métricas
Referências
World Psychiatric Association. A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders. World Psychiatry. 2011;10(2):86-92. PMid:21633677 PMCid:PMC3104876. DOI: https://doi.org/10.1002/j.2051-5545.2011.tb00022.x
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: APA; 2013. DOI: https://doi.org/10.1176/appi.books.9780890425596
Cosgrove L, Wheeler EE. Drug firms, the codification of diagnostic categories, and bias in clinical guidelines. J Law Med Ethics [Internet]. 2013;14(3):1-27. Disponível em: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2286724
St-Onge JC. Tous fous? L’influence de l’industrie pharmaceutique sur la psychiatrie. Montréal: Ecosociété; 2013.
Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. Br Med J. 2002;324(7342):886-891. http://dx.doi.org/10.1136/bmj.324.7342.886 DOI: https://doi.org/10.1136/bmj.324.7342.886
Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. 2007;4(4):e150. PMid:17455991 PMCid:PMC1876413. http://dx.plos.org/10.1371/journal.pmed.0040150 DOI: https://doi.org/10.1371/journal.pmed.0040150
Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, Durrieu G, et al. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States. J Gen Intern Med. 2013;10:1368-1375. PMid:23558775. http://dx.doi.org/10.1007/s11606-013-2411-7 DOI: https://doi.org/10.1007/s11606-013-2411-7
Sah S, Fugh-Berman A. Physicians under the influence: social psychology and industry marketing strategies. J Law Med Ethics [Internet]. 2013;14(3):1-27. Disponível em: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2286433
Taylor F, Huffman MD, Macedo AF, Moore THM, Burke M, Smith GD, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1. http://dx.doi.org/10.1002/14651858.CD004816.pub5 DOI: https://doi.org/10.1002/14651858.CD004816.pub5
Cathébras P. [Doctor Knock lives at Wall Street. The new targets of pharmaceutical industry]. Rev Med Interne. 2003;24(8):538-41. PMid:12888175. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/12888175 DOI: https://doi.org/10.1016/S0248-8663(03)00195-4
Goldacre B, Bad pharma: how drug companies mislead doctors and harm patients. London: Faber & Faber; 2012
Parry V. The art of branding a condition. Med Mark Media [Internet]. 2003;38(5)43-49 Disponível em: http://www.ybranding.com/Content/pdf/TheArtofBrandingaCondition.pdf.
Heath I. Combating disease mongering: daunting but nonetheless essential. PLoS Medicine. 2006;3(4):e146. PMid:16597174 PMCid:PMC1434491. http://dx.doi.org/10.1371/journal.pmed.0030146 DOI: https://doi.org/10.1371/journal.pmed.0030146
Brownlee S. Overtreated: why too much medicine is making us sicker and poorer. USA: Bloomsbury; 2008.
Light DW, Lexchin J, Darrow JJ. Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs. J Law, Med Ethics. 2013;14(3):590-600. DOI: https://doi.org/10.1111/jlme.12068
Dumit J. Drugs for life. Durham: Duke University Press; 2012. PMCid:PMC3342335. http://dx.doi.org/10.1215/9780822393481 DOI: https://doi.org/10.1215/9780822393481
Welch HG, Schwartzl L, Woloshin S. Overdiagnosed. Boston: Beacon Press; 2011.
Morell Sixto, ME, Martínez González,C, Quintana Gómez, JL. Disease mongering, el lucrativo negocio de la promoción de enfermedades. Rev Pediatr Aten Primaria. 2009;11(43)491-512. http://dx.doi.org/10.4321/S1139-76322009000400011 DOI: https://doi.org/10.4321/S1139-76322009000400011
Moynihan R. A new deal on disease definition. Br Med J. 2011;342:d2548-d2548. PMid:21540259. http://dx.doi.org/10.1136/bmj.d2548 DOI: https://doi.org/10.1136/bmj.d2548
Zahl PH, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol [Internet]. 2011;12(12):1118-1124 [acesso em 2011 Oct 17]. PMid:21996169. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/21996169 DOI: https://doi.org/10.1016/S1470-2045(11)70250-9
Gøtzsche PC, Gotzsche PG. Mammography screening: truth, lies and controversy. Radcliffe Publishing [Internet]; 2012. p. 400. [acesso em 2012 Feb 3]. Disponível em: http://www.radcliffe-oxford.com/books/bookdetail.aspx?ISBN=1846195853
Meador CK. The art and science of non disease. New Engl J Med. 1965;14(272):92-95 http://dx.doi.org/10.1056/NEJM196501142720208 DOI: https://doi.org/10.1056/NEJM196501142720208
Smith R. In search of "non-disease". Br Med J. 2002;324(7342):883-885. http://dx.doi.org/10.1136/bmj.324.7342.883 DOI: https://doi.org/10.1136/bmj.324.7342.883
Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130(11):910-921. http://dx.doi.org/10.7326/0003-4819-130-11-199906010-00016 DOI: https://doi.org/10.7326/0003-4819-130-11-199906010-00016
Jamoulle M. Information et informatisation en médecine générale [Internet]. Belgium: Presses Universitaires de Namur; 1986. p. 193-209. Disponível em: http://www.ph3c.org/PH3C/docs/27/000103/0000405.pdf
Jamoulle M, Roland M. Prévention quaternaire De Wonca world Hong Kong 1995 à Wonca world Prague 2013. Wonca world Prague [Internet]. 2013. Poster. Disponível em: http://www.ph3c.org/PH3C/docs/27/000284/0000440.pdf.
Jamoulle M. A propos d'un dessin. Ethica Clinica [Internet]. 2013;70:28-31. Disponível em: http://www.ph3c.org/PH3C/docs/27/000281/0000416.pdf.
Illich I. Némésis médicale: l'expropriation de la santé. Paris: Seuil; 1975.
Carpentier J. Medical flipper. Paris: La Découverte; 1989. Cahiers libres, 402.
Balint M. The doctor, his patient, and the illness. Edinburgh: Churchill Livingstone; 1964.
McWhinney IR, Freeman T. A Textbook of family medicine. 2th ed. Oxford University Press; 1997.
Jamoulle M. Déclaration d'intention; Le médecin généraliste et de famille et l'usager de drogue [Internet]. 1997. Disponível em: http://www.ulb.ac.be/esp/mfsp/ethitox-fr.html
World Organization of National Colleges - WONCA International Classification Committtee. An international glossary for general/family practice. Fam Pract [Internet]. 1995;12(3):341-369. http://dx.doi.org/10.1093/fampra/12.3.341 DOI: https://doi.org/10.1093/fampra/12.3.341
Jamoulle M, Roland M. Quaternary prevention and the glossary of general practice/family medicine. Hong Kong: WICC; 1995.
Bentzen N. Wonca dictionary of general/family practice. Copenhagen: Wonca International Classification Committtee; 2003.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Ao submeterem um manuscrito à RBMFC, os autores mantêm a titularidade dos direitos autorais sobre o artigo, e autorizam a RBMFC a publicar esse manuscrito sob a licença Creative Commons Atribuição 4.0 e identificar-se como veículo de sua publicação original.
